Avesta Biotherapeutics and Research Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Latest Deal Type
  • Joint Venture
  • Financing Rounds
  • 1
  • Investments
  • 1

Avesta Biotherapeutics and Research General Information

Description

Manufacturer of targeted therapies and biopharmaceuticals in India. The company exploits opportunities in biological contract manufacturing and focuses on development of bio-pharmaceuticals in the area of autoimmune disorders and cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Avesthagen One No. 7/6
  • Brunton Road
  • Bangalore, Karnataka 560025
  • India
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avesta Biotherapeutics and Research Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avesta Biotherapeutics and Research‘s full profile, request access.

Request a free trial

Avesta Biotherapeutics and Research Board Members (2)

Name Representing Role Since
00000000 0000000 Avesta Biotherapeutics and Research Board Member 000 0000
000000 000000 00.0 Self Board Member 000 0000
To view Avesta Biotherapeutics and Research’s complete board members history, request access »

Avesta Biotherapeutics and Research Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avesta Biotherapeutics and Research‘s full profile, request access.

Request a free trial

Avesta Biotherapeutics and Research Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 05-Oct-2007 000000000000000000 Other Pharmaceuticals and Biotechnology
To view Avesta Biotherapeutics and Research’s complete acquisitions history, request access »